Koyfin Home > Directory > Health Care > Alexion Pharm Inc > Repurchase of Common Stock

Alexion Pharm Inc Repurchase of Common Stock Chart (ALXN)

Alexion Pharm Inc annual/quarterly Repurchase of Common Stock from 2012 to 2020.
  • Alexion Pharm Inc Repurchase of Common Stock for the quarter ending September 09, 2020 was $-74m a 55.78% decrease of -41m year over year
  • Alexion Pharm Inc Repurchase of Common Stock for the last 12 months ending September 09, 2020 was $-467m a 10.88% decrease of -51m year over year
  • Alexion Pharm Inc Annual Repurchase of Common Stock for 2019 was $-416m a 79.57% decrease of -331m from 2018
  • Alexion Pharm Inc Annual Repurchase of Common Stock for 2018 was $-85m a -445.41% increase of 379m from 2017
  • Alexion Pharm Inc Annual Repurchase of Common Stock for 2017 was $-464m a 7.12% decrease of -33m from 2016
Other Cash Flow Metrics:
  • Alexion Pharm Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $387m a 33.45% increase of 130m year over year
  • Alexion Pharm Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $227m a 35.57% increase of 81m year over year
  • Alexion Pharm Inc Total Revenue for the quarter ending December 12, 2018 was $1,129m a 17.53% increase of 198m year over year
View Chart On Koyfin

Quarterly ALXN Repurchase of Common Stock Data

09/2020$-74m
06/2020$-254m
03/2020$-107m
12/2019$-33m
09/2019$-335m
06/2019$-38m
03/2019$-11m
12/2018$0m
09/2018$0m
06/2018$0m

Annual ALXN Repurchase of Common Stock Data

2019$-416m
2018$-85m
2017$-464m
2016$-431m
2015$-328m
2014$-303m
2013$-66m
2012$-12m